Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm Metastasis × FOLFOXIRI protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10 Rectal Neoplasms 9 Colonic Neoplasms 4 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Metastasis Colon Cancer 1 Carcinoma, Neuroendocrine 1

Interventions

Radiosurgery 74 Capecitabine 70 Bevacizumab 62 Oxaliplatin 60 Fluorouracil 59 Gemcitabine 55 Leucovorin 52 Nivolumab 48 pembrolizumab 46 Paclitaxel 41 Irinotecan 39 Radiotherapy 38 Cisplatin 34 Magnetic Resonance Spectroscopy 31 Everolimus 31 Cyclophosphamide 31 Cetuximab 31 Drug Therapy 30 Docetaxel 29 Ipilimumab 28 Carboplatin 27 Trastuzumab 25 Sorafenib 24 Sunitinib 23 Erlotinib Hydrochloride 20 Surveys and Questionnaires 18 Specimen Handling 18 Doxorubicin 18 Surgical Procedures, Operative 17 Biopsy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015923 2021-03-16

CCRe-IV

Hospital Universitari de Bellvitge

Phase 4 Terminated

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡